Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00478829
Status:
COMPLETED
Last Update Posted:
2007-12-06
First Post:
2007-05-24
Brief Title:
Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in 5 Large Cities in China
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objectives Primary To estimate the prevalence of depression andor anxiety disorder in outpatients attending the general health care settings in China
Secondary
To estimate gender- and age-specific prevalence of depression andor anxiety disorder in outpatients attending the general health care settings in China
To estimate the prevalence of depression andor anxiety disorder in outpatients attending the general health care settings such as departments of neurology gastroenterology cardiology and gynecology
To describe the recognition and treatment rate by treating physicians as depression andor anxiety for outpatients in the general health care settings in China
Secondary
To estimate gender- and age-specific prevalence of depression andor anxiety disorder in outpatients attending the general health care settings in China
To estimate the prevalence of depression andor anxiety disorder in outpatients attending the general health care settings such as departments of neurology gastroenterology cardiology and gynecology
To describe the recognition and treatment rate by treating physicians as depression andor anxiety for outpatients in the general health care settings in China
Detailed Description:
This study is designed to investigate the status of identifying depression andor anxiety disorder with somatic symptoms in general hospitals in China The study will generate valuable information to the medical community therefore the early and vigorous treatment is possible Its in line with China government authorities target to increase the recognition rate of depression andor anxiety in primary care settings to more than 50 by the end of 2010 The study will also help to identify specific diagnosis and treatment patterns for depressive anxious patients and their comorbid conditions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None